Episodes 31-39 of 39
Watch Expert Insights on Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
Medical Industry FeatureWatch Expert Insights on Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
Examining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emerging Personalized Medicine
Medical Industry FeatureExamining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emerging Personalized Medicine
Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Medical Industry FeaturePathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Medical Industry FeatureExperts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Medical Industry FeatureInvestigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
Medical Industry FeatureAddressing Hesitancy on Biosimilars: From Development to Clinical Practice
Investigating Imaging Techniques in Multiple Myeloma
Medical Industry FeatureInvestigating Imaging Techniques in Multiple Myeloma
5-Year Follow-Up Update of the MAIA Study
Medical Industry Feature5-Year Follow-Up Update of the MAIA Study
Key Considerations for G-CSF Administration in Patients with FN Risk
Medical Industry FeatureKey Considerations for G-CSF Administration in Patients with FN Risk
